Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-Analysis

BackgroundCardiac resynchronization therapy (CRT) could be considered for heart failure (HF) patients with atrial fibrillation (AF) unless a potent ventricular capture strategy is conducted. However, the benefit of a pacemaker (PM; as part of CRT) in patients with AF and whether atrioventricular jun...

Full description

Bibliographic Details
Main Authors: Chi Zhang, Xi-Ying Wang, Lian Lou, Xuan Zhang, Le-Le Chen, Yu-Xiao Chen, Jian Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.587297/full
_version_ 1798015586378186752
author Chi Zhang
Xi-Ying Wang
Lian Lou
Xuan Zhang
Le-Le Chen
Yu-Xiao Chen
Jian Yang
author_facet Chi Zhang
Xi-Ying Wang
Lian Lou
Xuan Zhang
Le-Le Chen
Yu-Xiao Chen
Jian Yang
author_sort Chi Zhang
collection DOAJ
description BackgroundCardiac resynchronization therapy (CRT) could be considered for heart failure (HF) patients with atrial fibrillation (AF) unless a potent ventricular capture strategy is conducted. However, the benefit of a pacemaker (PM; as part of CRT) in patients with AF and whether atrioventricular junction (or nodal) ablation (AVAB) can improve the prognosis of these patients compared with those treated medically to support ventricular capture are unclear.Methods and ResultsSystematic reviews and meta-analyses investigating the roles of PMs and AVAB in patients with AF were obtained in a search of the PubMed, Embase, and Medline databases and then analyzed with respect to the following outcomes: mortality, left ventricular ejection fraction, and clinical findings including the New York Heart Association class, 6-min walk distance (6MWD), quality of life as assessed in a specific questionnaire, and response to CRT. The quality of the included reviews was assessed using the Assessing the Methodological Quality of Systematic Reviews 2 tool, which includes 16 items. This study was finally based on 13 systematic reviews or meta-analyses. The results showed that patients with AF have higher all-cause mortality rates compared with patients with sinus rhythm and that AVAB can reduce all-cause mortality in patients with AF. Although the functional improvement was better in sinus rhythm than in patients with AF, in the latter, AVAB increased the 6MWD and reduced the CRT nonresponse rate in patients with AF.ConclusionAtrial fibrillation is associated with a higher all-cause mortality rate in patients with CRT implantation. AVAB, by increasing the 6MWD and survival, can improve the prognosis of these patients.
first_indexed 2024-04-11T15:36:59Z
format Article
id doaj.art-9048051d820d495db4f8cc37a5841ae1
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-04-11T15:36:59Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-9048051d820d495db4f8cc37a5841ae12022-12-22T04:15:56ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2022-01-01810.3389/fcvm.2021.587297587297Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-AnalysisChi ZhangXi-Ying WangLian LouXuan ZhangLe-Le ChenYu-Xiao ChenJian YangBackgroundCardiac resynchronization therapy (CRT) could be considered for heart failure (HF) patients with atrial fibrillation (AF) unless a potent ventricular capture strategy is conducted. However, the benefit of a pacemaker (PM; as part of CRT) in patients with AF and whether atrioventricular junction (or nodal) ablation (AVAB) can improve the prognosis of these patients compared with those treated medically to support ventricular capture are unclear.Methods and ResultsSystematic reviews and meta-analyses investigating the roles of PMs and AVAB in patients with AF were obtained in a search of the PubMed, Embase, and Medline databases and then analyzed with respect to the following outcomes: mortality, left ventricular ejection fraction, and clinical findings including the New York Heart Association class, 6-min walk distance (6MWD), quality of life as assessed in a specific questionnaire, and response to CRT. The quality of the included reviews was assessed using the Assessing the Methodological Quality of Systematic Reviews 2 tool, which includes 16 items. This study was finally based on 13 systematic reviews or meta-analyses. The results showed that patients with AF have higher all-cause mortality rates compared with patients with sinus rhythm and that AVAB can reduce all-cause mortality in patients with AF. Although the functional improvement was better in sinus rhythm than in patients with AF, in the latter, AVAB increased the 6MWD and reduced the CRT nonresponse rate in patients with AF.ConclusionAtrial fibrillation is associated with a higher all-cause mortality rate in patients with CRT implantation. AVAB, by increasing the 6MWD and survival, can improve the prognosis of these patients.https://www.frontiersin.org/articles/10.3389/fcvm.2021.587297/fullatrial fibrillationheart failurebiventricular pacingatrioventricular junction ablationrate control
spellingShingle Chi Zhang
Xi-Ying Wang
Lian Lou
Xuan Zhang
Le-Le Chen
Yu-Xiao Chen
Jian Yang
Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-Analysis
Frontiers in Cardiovascular Medicine
atrial fibrillation
heart failure
biventricular pacing
atrioventricular junction ablation
rate control
title Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-Analysis
title_full Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-Analysis
title_fullStr Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-Analysis
title_full_unstemmed Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-Analysis
title_short Pacemaker and Atrioventricular Junction Ablation in Patients With Atrial Fibrillation—A Systematic Review of Systematic Review and Meta-Analysis
title_sort pacemaker and atrioventricular junction ablation in patients with atrial fibrillation a systematic review of systematic review and meta analysis
topic atrial fibrillation
heart failure
biventricular pacing
atrioventricular junction ablation
rate control
url https://www.frontiersin.org/articles/10.3389/fcvm.2021.587297/full
work_keys_str_mv AT chizhang pacemakerandatrioventricularjunctionablationinpatientswithatrialfibrillationasystematicreviewofsystematicreviewandmetaanalysis
AT xiyingwang pacemakerandatrioventricularjunctionablationinpatientswithatrialfibrillationasystematicreviewofsystematicreviewandmetaanalysis
AT lianlou pacemakerandatrioventricularjunctionablationinpatientswithatrialfibrillationasystematicreviewofsystematicreviewandmetaanalysis
AT xuanzhang pacemakerandatrioventricularjunctionablationinpatientswithatrialfibrillationasystematicreviewofsystematicreviewandmetaanalysis
AT lelechen pacemakerandatrioventricularjunctionablationinpatientswithatrialfibrillationasystematicreviewofsystematicreviewandmetaanalysis
AT yuxiaochen pacemakerandatrioventricularjunctionablationinpatientswithatrialfibrillationasystematicreviewofsystematicreviewandmetaanalysis
AT jianyang pacemakerandatrioventricularjunctionablationinpatientswithatrialfibrillationasystematicreviewofsystematicreviewandmetaanalysis